Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
C Tarn, L Rink, E Merkel, D Flieder… - Proceedings of the …, 2008 - National Acad Sciences
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFR α. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
and PDGFR α. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
[PDF][PDF] Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
C Tarn, L Rink, E Merkel, D Flieder, H Pathak… - PNAS, 2008 - researchgate.net
Results IGF1R Is Highly Expressed in WT GISTs. High-density singlenucleotide
polymorphism (SNP) arrays were used to evaluate changes in gene copy number in GISTs …
polymorphism (SNP) arrays were used to evaluate changes in gene copy number in GISTs …
Insulin-Like Growth Factor 1 Receptor Is a Potential Therapeutic Target for Gastrointestinal Stromal Tumors
C Tarn, L Rink, E Merkel, D Flieder, H Pathak… - Proceedings of the …, 2008 - JSTOR
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
C Tarn, L Rink, E Merkel, D Flieder… - Proceedings of the …, 2008 - europepmc.org
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
C Tarn, L Rink, E Merkel, D Flieder, H Pathak… - Proceedings of the …, 2008 - cir.nii.ac.jp
抄録< jats: p> A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function
mutations in c-< jats: italic> KIT</jats: italic> and< jats: italic> PDGFR</jats: italic> α. These …
mutations in c-< jats: italic> KIT</jats: italic> and< jats: italic> PDGFR</jats: italic> α. These …
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
C Tarn, L Rink, E Merkel, D Flieder… - Proceedings of the …, 2008 - pubmed.ncbi.nlm.nih.gov
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFRalpha. These so-called wild-type (WT) GISTs tend to be less responsive to …
and PDGFRalpha. These so-called wild-type (WT) GISTs tend to be less responsive to …
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
C Tarn, L Rink, E Merkel, D Flieder… - Proceedings of the …, 2008 - ui.adsabs.harvard.edu
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
[HTML][HTML] Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
C Tarn, L Rink, E Merkel, D Flieder… - Proceedings of the …, 2008 - ncbi.nlm.nih.gov
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
C Tarn, L Rink, E Merkel, D Flieder… - Proceedings of the …, 2008 - europepmc.org
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …
and PDGFRα. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib …